Skip to main content
×
×
Home

Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity

  • E. Leuci (a1), L. Manenti (a2) and C. Maggini (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity
      Available formats
      ×
Abstract
Copyright
References
Hide All
Chengappa, K. N., Carpenter, A. B., Keshavan, M. S. et al (1991) Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated shizophrenic patients. Biological Psychiatry 30, 731735.
Erkan, D. & Lockshin, M. D. (2006) Antiphospholipid syndrome. Current Opinion in Rheumatology, 18, 242248.
Joukamaa, M., Heliovaara, M., Knekt, P., et al (2006) Schizophrenia, neuroleptic medication and mortality British Journal of Psychiatry 188, 122127.
Oomen, H. A., Wekking, F. M., de Jong, J., et al (1995) Screening psychiatric admissions for anticardiolipin antibody. Psychiatry Research, 58, 8388.
Schwartz, M. D., Rochas, M., Weller, B. et al (1998) High association of anticardiolipin antibodies with psychosis. Journal of Clinical Psychiatry 59, 2023.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 10 *
Loading metrics...

Abstract views

Total abstract views: 33 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 26th May 2018. This data will be updated every 24 hours.

Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity

  • E. Leuci (a1), L. Manenti (a2) and C. Maggini (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *